{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:03:43Z","timestamp":1747155823936,"version":"3.40.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalsofvascularsurgery.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.avsg.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T11:35:04Z","timestamp":1488368104000},"page":"306.e5-306.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Medical Management of Extensive Arterial Thromboembolism in a Patient with Essential Thrombocythemia and Warfarin Failure"],"prefix":"10.1016","volume":"42","author":[{"given":"Aisha K.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-7282","authenticated-orcid":false,"given":"Alicia","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nedaa","family":"Skeik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2017.01.004_bib1","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1002\/cncr.24440","article-title":"The 2008 World Health Organization classification system for myeloproliferative neoplasms","volume":"115","author":"Tefferi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.avsg.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2017.01.004_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.avsg.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2017.01.004_bib5","first-page":"112","article-title":"JAK2 V617F: a single mutation in the myeloproliferative group of disorders","volume":"75","author":"McLornan","year":"2006","journal-title":"Ulster Med J"},{"key":"10.1016\/j.avsg.2017.01.004_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMra035363","article-title":"Thrombocytosis","volume":"350","author":"Schafer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2017.01.004_bib7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2010-08-270033","article-title":"How I treat essential thrombocythemia","volume":"117","author":"Beer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2017.01.004_bib8","first-page":"177","article-title":"Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group","volume":"23","author":"Murphy","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1016\/j.avsg.2017.01.004_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","article-title":"Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors","volume":"83","author":"Watson","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.avsg.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.avsg.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2007-05-091850","article-title":"Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes","volume":"111","author":"Wilkins","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2017.01.004_bib12","series-title":"Risk-based management in essential thrombocythemia. ASH Education Program Book","first-page":"172","author":"Tefferi","year":"1999"},{"key":"10.1016\/j.avsg.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2011.1.215","article-title":"Management of essential thrombocythemia","volume":"2011","author":"Cervantes","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.avsg.2017.01.004_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.avsg.2017.01.004_bib15","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9","article-title":"Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis","volume":"52","author":"Bucalossi","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.avsg.2017.01.004_bib17","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","article-title":"Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients","volume":"67","author":"Colombi","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.avsg.2017.01.004_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajh.2830200408","article-title":"The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases","volume":"20","author":"Buss","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1016\/j.avsg.2017.01.004_bib19","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.avsg.2017.01.004_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/1538574416642875","article-title":"A unique case of aortic thrombosis with elevated lipoprotein(a)","volume":"50","author":"Ostertag-Hill","year":"2016","journal-title":"Vasc endovascular surg"},{"key":"10.1016\/j.avsg.2017.01.004_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.CIR.96.1.288","article-title":"Mobile thromboses of the aortic arch without aortic debris a transesophageal echocardiographic finding associated with unexplained arterial embolism","volume":"96","author":"Laperche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2017.01.004_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1752-1947-4-219","article-title":"Aortic thrombus in a patient with myeloproliferative thrombocytosis, successfully treated by pharmaceutical therapy: a case report","volume":"4","author":"Yamamoto","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.avsg.2017.01.004_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0741-5214(95)70013-7","article-title":"Essential thrombocytosis: underemphasized cause of large-vessel thrombosis","volume":"22","author":"Johnson","year":"1995","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2017.01.004_bib24","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.jacc.2016.09.958","article-title":"Prosthetic Heart Valve Thrombosis","volume":"68","author":"Dangas","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509616308688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509616308688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T02:26:07Z","timestamp":1568859967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509616308688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":24,"alternative-id":["S0890509616308688"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2017.01.004","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Management of Extensive Arterial Thromboembolism in a Patient with Essential Thrombocythemia and Warfarin Failure","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}